Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 18/20 | 0.74 |
| ▸ | NMBR | P28336 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27378954 | 0.95 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL27379518 | 0.95 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL4341688 | 0.92 | GRPR (0.73) | GRPRNMBR | |
| SCHEMBL6510905 | 0.92 | GRPR (0.68) | GRPR | |
| SCHEMBL29663974 | 0.92 | GRPR (0.68) | GRPR | |
| SCHEMBL2193571 | 0.91 | GRPR (0.67) | GRPRNMBR | |
| SCHEMBL38659985 | 0.91 | GRPR (0.68) | GRPRNMBR | |
| SCHEMBL25081963 | 0.91 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL25081959 | 0.91 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL24253291 | 0.91 | GRPR (0.69) | GRPRNMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030050436-A1 | Octapeptide bombesin analogs | BIOMEASURE INC., MASSACHUSETTS CORPORATION | 2003-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050436-A1 | Octapeptide bombesin analogs | GRPR, GHRHR, VGF | GRPR 1/4885NMBR 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.